S66 — Star Combo Pharma Share News
0.000.00%
- AU$18.91m
- AU$5.09m
- AU$24.45m
Australia Stock Exchange release from STAR COMBO PHARM : Appendix 4D Half Yearly Report
Australia's Star Combo Pharma rises; posts strong Q2 group revenue
Brief: Star Combo Pharma Says Q2 Revenue Up 6%
Australia Stock Exchange release from STAR COMBO PHARM : S66 Quarterly Business Update
Australia Stock Exchange release from STAR COMBO PHARM : S66 Cancellation of Shares
Australia Stock Exchange release from STAR COMBO PHARM : S66 Results of AGM Voting
Australia Stock Exchange release from STAR COMBO PHARM : CEO Presentation to S66 AGM
Australia Stock Exchange release from STAR COMBO PHARM : S66 Investor Webinar Presentation 6 Nov 2020
Australia Stock Exchange release from STAR COMBO PHARM : S66 Quarterly Update
Australia Stock Exchange release from STAR COMBO PHARM : S66 App 4G and Corporate Governance Statement
Australia Stock Exchange release from STAR COMBO PHARM : Annual Report to shareholders
Australia Stock Exchange release from STAR COMBO PHARM : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from STAR COMBO PHARM : Appointment of Auditor
Australia Stock Exchange release from STAR COMBO PHARM : S66 Investor Roadshow Presentation September 2020
Brief: Star Combo Pharma Announces Expansion Of Manufacturing Capabilities At NSW Site
Australia Stock Exchange release from STAR COMBO PHARM : 11m Transformational Investment
Australia Stock Exchange release from STAR COMBO PHARM : PRE_NR Ends: 12:54:57
Australia Stock Exchange release from STAR COMBO PHARM : FY 2020 Results Commentary
Australia Stock Exchange release from STAR COMBO PHARM : Preliminary Final Report